Cargando…
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
Autores principales: | Evans, D Gareth R, Howell, Anthony, Ingham, Sarah L, Buchan, Iain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672730/ https://www.ncbi.nlm.nih.gov/pubmed/23448362 http://dx.doi.org/10.1186/bcr3382 |
Ejemplares similares
-
Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
por: Prosperi, Mattia CF, et al.
Publicado: (2014) -
Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
por: Dominguez-Valentin, Mev, et al.
Publicado: (2018) -
Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010) -
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients
por: Lanjouw, Lieke, et al.
Publicado: (2023) -
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies
por: Buckingham, Lela, et al.
Publicado: (2019)